Catalyst Wire Dossier Catalyst Wire Dossier

methylphenidate (long-acting formulation)

methylphenidate · Janssen-Cilag Farmaceutica Ltda.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for methylphenidate (long-acting formulation), covering 2013-07-23 to 2013-07-23. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Quality of Life of Long-Acting Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]

See pricing